It's time to finally put an end to “what the market will bear” as a method of pricing prescription drugs.
Leigh Purvis, MPA
Advertisement
Leigh Purvis is the director of Health Services Research in AARP's Public Policy Institute. She leads a team of policy analysts and researchers who work on healthcare issues that are relevant to the 50 population. In addition, Ms Purvis heads the Institute's work on prescription drug and mental health issues. Her primary areas of expertise are prescription drug pricing, biologic drugs, and prescription drug coverage.
Articles by Leigh Purvis, MPA
Advertisement
Latest Updated Articles
- Are We Finally Ready to Rethink Prescription Drug Pricing?
Published: January 8th 2016 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
After Narrow Miss in Phase 3 Study, IO Biotech Ponders Next Steps for Immune-Modulatory, Off-the-Shelf Cancer Vaccine
2
Ongoing COVID-19 Circulation Linked to Increases in Health-Related Work Absences, Workforce Exits
3
3 New Study Findings to Look Out for at Menopause Society 2025
4
Guidelines for Bronchiectasis Highlight Multiple Treatment Methods
5
